Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018300 · ClinicalTrials.gov registry record · NA
Iron Supplementation and Side Effects
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04018300 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 17 participants.
The verdict
NCT04018300, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The objective of this study is to examine patient-reported gastrointestinal side effects, as well as iron status indicators, inflammatory markers and oxidative stress following administration of ferrous sulfate and iron-enriched Aspergillus oryzae supplementation.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ferrous sulfate
- DIETARY_SUPPLEMENT Aspiron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04018300
The ClinicalTrials.gov registry entry for NCT04018300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04018300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04018300 about?
NCT04018300 is a clinical study titled "Iron Supplementation and Side Effects". The objective of this study is to examine patient-reported gastrointestinal side effects, as well as iron status indicators, inflammatory markers and oxidative stress following administration of ferrous sulfate and iron-enriched Aspergillus oryzae supplementation.
What is the current status of trial NCT04018300?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-01-08. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT04018300?
The interventions under investigation include: Placebo (OTHER), Ferrous sulfate (DIETARY_SUPPLEMENT), Aspiron (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04018300?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.